NCT06094504
Spectral Lighting and Intestinal Failure
Enrolling by Invitation
NAUp to 1InterventionalBasic scienceChildren's Hospital Medical Center, CincinnatiInvestigator-initiated
~32 participants
Updated 2024-12-16 on ClinicalTrials.gov
What's tested:Spectral Lighting
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
plasma protein concentration of insulin
Measured over For four weeks, once a week for each lighting condition and once a week during the predawn hours after each lighting condition, for a total of four samples per week.
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesOhio1
Study leadership
- James M Greenberg, MD · PRINCIPAL_INVESTIGATOR · Children's Hospital Medical Center, Cincinnati
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
greater than or equal to 32 weeks post-menstrual age (PMA)
diagnosis or anticipated diagnosis of intestinal failure by qualified provider
have an anticipated hospital stay of at least 5 weeks following initiation of study participation
Exclusion
Infants with major congenital anomalies outside of the gastrointestinal tract
Infants with aneuploidy (having an abnormal amount of chromosomes)
Infants \<32 weeks post-menstrual age (PMA)
Infants who are anticipated to require a major surgery after enrollment other than anastomosis.
What this trial measures
- plasma protein concentration of insulinFor four weeks, once a week for each lighting condition and once a week during the predawn hours after each lighting condition, for a total of four samples per week.
Protein concentrations of plasma insulin as analyzed by SomaScan large scale proteomics assay will be compared among plasma samples taken in lighting conditions and between each lighting condition and dark.
- plasma protein concentration of leptinFor four weeks, once a week for each lighting condition and once a week during the predawn hours after each lighting condition, for a total of four samples per week.
Protein concentrations of plasma insulin as analyzed by SomaScan large scale proteomics assay will be compared among plasma samples taken in lighting conditions and between each lighting condition and dark.